Patents by Inventor Amy ROETTGER

Amy ROETTGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dialysis prescription optimization for decreased arrhythmias
    Patent number: 11395868
    Abstract: Systems and methods are provided for determining an estimated risk of arrhythmia during or after dialysis based on changes in serum potassium concentration of a patient and an amount of fluid removed from the patient during dialysis. The systems and methods allow for a determination of a risk that arrhythmia will occur due to the changes in potassium and fluid volume of a patient during dialysis, and for optimizing a dialysis prescription in order to minimize the risk of arrhythmia.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: July 26, 2022
    Assignee: Medtronic, Inc.
    Inventors: Amy Roettger, VenKatesh R. Manda, John Burnes, Rebecca Poindexter, Martin T. Gerber
  • DIALYSIS PRESCRIPTION OPTIMIZATION FOR DECREASED ARRHYTHMIAS
    Publication number: 20190262529
    Abstract: Systems and methods are provided for determining an estimated risk of arrhythmia during or after dialysis based on changes in serum potassium concentration of a patient and an amount of fluid removed from the patient during dialysis. The systems and methods allow for a determination of a risk that arrhythmia will occur due to the changes in potassium and fluid volume of a patient during dialysis, and for optimizing a dialysis prescription in order to minimize the risk of arrhythmia.
    Type: Application
    Filed: May 14, 2019
    Publication date: August 29, 2019
    Inventors: Amy ROETTGER, VenKatesh R. MANDA, John BURNES, Rebecca POINDEXTER, Martin T. GERBER
  • Dialysis prescription optimization for decreased arrhythmias
    Patent number: 10335534
    Abstract: Systems and methods are provided for determining an estimated risk of arrhythmia during or after dialysis based on changes in serum potassium concentration of a patient and an amount of fluid removed from the patient during dialysis. The systems and methods allow for a determination of a risk that arrhythmia will occur due to the changes in potassium and fluid volume of a patient during dialysis, and for optimizing a dialysis prescription in order to minimize the risk of arrhythmia.
    Type: Grant
    Filed: October 25, 2016
    Date of Patent: July 2, 2019
    Assignee: Medtronic, Inc.
    Inventors: Amy Roettger, VenKatesh R. Manda, John Burnes, Rebecca Poindexter, Martin T. Gerber
  • DIALYSIS PRESCRIPTION OPTIMIZATION FOR DECREASED ARRHYTHMIAS
    Publication number: 20170128657
    Abstract: Systems and methods are provided for determining an estimated risk of arrhythmia during or after dialysis based on changes in serum potassium concentration of a patient and an amount of fluid removed from the patient during dialysis. The systems and methods allow for a determination of a risk that arrhythmia will occur due to the changes in potassium and fluid volume of a patient during dialysis, and for optimizing a dialysis prescription in order to minimize the risk of arrhythmia.
    Type: Application
    Filed: October 25, 2016
    Publication date: May 11, 2017
    Inventors: Amy ROETTGER, VenKatesh R. MANDA, John BURNES, Rebecca POINDEXTER, Martin T. GERBER